摘要:
A process for preparing a multilayer film having at least one polyamide layer include the steps of forcing out from a T-die by co-extrusion a multi-layer film having a layer containing about 50 to about 95% by weight of a crystalline polyamide and about 50 to about 5% by weight of an amorphous polyamide, and stretching the film at least in the lateral direction.
摘要:
The invention provides a multi-layer film having 1 to 4 polyamide layers, characterized in that at least one polyamide layer comprises about 50 to about 95% by weight of a crystalline polyamide and about 50 to about 5% by weight of an amorphous polyamide and that the multi-layer film is produced by stretching a flat film at least in the lateral direction; and a process for preparing the multi-layer film.
摘要:
A connecting method of connecting covered wires with each other and recessed resinous tips used in the method are provided. In the method, it is executed at the first step to put a connecting part constituted by a shield wire and a ground wire between a first resin tip and a second resin tip. The first resin tip has, around the connecting part, first recessed parts for accommodating the molten cover of the shield wire and second recessed parts for accommodating the molten cover of the ground wire. The second resin tip has second recessed parts formed for accommodating the molten cover of the ground wire.
摘要:
The present invention relates to a method for treating a cancer comprising orally administering a composition containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride in a molar ratio of 1:0.5 at a dose of 20 to 80 mg/m2/day in terms of FTD in 2 to 4 divided portions per to patients in need of the treatment.
摘要翻译:本发明涉及一种治疗癌症的方法,包括口服给予含有α,α,α-三氟胸苷(FTD)和5-氯-6-(1-(2-亚氨基吡咯烷基)甲基)尿嘧啶盐酸盐的组合物,摩尔比 为1至0.5,剂量为20至80mg / m 2 /天,以FTD计,每2至4次分割,需要治疗的患者。
摘要:
In a retractor wherein webbing is drawn out from a take-up spool and extends partially around a drum, a locking device for the webbing for the seat belt is provided with a sensor for sensing sudden acceleration or deceleration exerted on a vehicle body. A first restraining pawl is moved by the sensor to a position preventing rotation of the spool. A second restraining pawl is driven by a tilting member to prevent rotation of the drum, and a frictional restraining member for pressing the webbing is provided on the base of the drum in a position opposed to a fixed frictional restraining member provided on the base of the retainer.
摘要:
In a shielding structure of a shielding electric wire in which the shielding electric wire and a ground wire are interposed between two resin members, and a compressive force is caused to act on the resin members and an ultrasonic wave is simultaneously applied to fuse the resin portions, thereby forming a shielded portion, a protruded portion 20 is provided on one of junction faces of the two resin members and a hole 21 including a protrusion inserting portion 21a for inserting the protruded portion 20 and a resin inflow portion 21b provided in an inner position from the protrusion inserting portion 21a and having a smaller width than a width of the protrusion inserting portion 21a is provided on the other junction face, and step faces at both sides on a boundary between the protrusion inserting portion 21a and the resin inflow portion 21b in the hole 21 are formed to be a pair of inclined faces 21c and 21c.
摘要:
In a shielded structure of a flat shielding electric wire, the flat shielding electric wire includes a plurality of shielding cores, an inner insulating sheathe covering each of the plurality of shielding cores, a conductive covering member covering the inner insulating sheathes, and a first outer insulating sheathe covering the conductive covering member. A pair of resin members sandwiches the flat shielding electric wire therebetween. A coating electric wire is provided between the flat shielding electric wire and one of the pair of resin members. The coating electric wire includes a conductive wire and a second outer insulating sheathe covering the conductive wire. The first outer insulating sheathe and the second outer insulating sheathe are fused by ultrasonic excitation so that the conductive wire is electrically connected to a part of the conductive covering member. At least one of the pair of resin members is formed with an ultrasonic attenuation groove so as to face at least a part of the second outer insulating sheathe.
摘要:
In a shield-processing structure of a shielded cable 1, the shielded cable 1 and an earth cable 2 are held between two resin members 3 and 3, and ultrasonic vibration is applied to the resin members 3 and 3 while exerting a compressive force between the resin members 3 and 3, thereby forming a shield-processed portion. A shielded cable-receiving groove 15 and an earth cable-receiving groove 16 are formed in a joint surface 3a of each of the resin members 3 and 3, and earth cable-holding projections 17 are formed on each of the joint surfaces 3a, and is disposed adjacent to the shielded cable-receiving groove 15, and projects into the earth cable-receiving groove 16. Opposite end portions 17a and 17a of a distal end surface of each of the earth cable-holding projections 17 are higher than a central portion 17b thereof.
摘要:
In at least one shielded core wire, a first conductive core wire is covered with a first insulating sheath. A conductive foil covers the at least one shielded core wire. A second insulating sheath covers the conductive foil. In a branch wire, a second conductive core wire is covered with a third insulating sheath. A part of the second insulating sheath and a part of the third insulating sheath are thermally fused so that the conductive foil and the second conductive core wire are electrically connected.
摘要:
A method for administering ECyd to a patient that realizes a continuous therapy without expressing peripheral neurotoxicity caused by ECyd and that exhibits an excellent therapeutic effect and prolongs patient survival. An antitumor agent containing ECyd or a salt thereof and a method of administering it to a cancer patient through continuous intravenous administration at a dose of 1.30 to 8.56 mg/m2 in terms of ECyd, for each administration period of 2 to 336 hours.
摘要翻译:一种向患者施用ECyd的方法,其实现连续治疗而不表现由ECyd引起的周围神经毒性,并且显示出优异的治疗效果并延长患者的存活。 含有ECyd或其盐的抗肿瘤剂和通过连续静脉内给药,以EC30为1.30〜8.56mg / m 2的剂量给予癌症患者的方法,每次给药期间为2〜336小时。